References
- Åstedt B. On fibrinolysis. Acta Obstet Gynecol Scand 1972; 18(Suppl)1–45
- Åstedt B. Demonstration of significance of placenta in depression of fibrinolytic activity during pregnancy. J Obstet Gynaecol Br Commonw 1972; 79: 205–6
- Holmberg L, Lecander I, Persson B, Åstedt B. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta 1978; 544: 128–37
- Walker J E., Gow L, Campbell D M., Ogston D. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemostas 1983; 49: 21–3
- Holmberg L, Kristoffersson A-C, Wallén P, Astedt B. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase. Scand J Clin Lab Invest 1982; 42: 347–53
- Burgos H, Hsi B-L, Yeh C-J G., Faulk W P. Plasminogen binding by human amniochorion. A possible factor in premature rupture of membranes. Am J Obstet Gynecol 1982; 143: 958–63
- Albrechtsen O K., Trolle D. A fibrinolytic system in human amniotic fluid. Acta Haemat 1955; 14: 376–82
- Yaffe H, Eldor A, Hornshtein E, Sadovsky E. Thromboplastic activity in amniotic fluid during pregnancy. Obstet Gynecol 1977; 50: 454–6
- Nilsson I M., Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1982; 123: 247–66
- Casslén B, Thorell J, Åstedt B. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid. Contraception 1981; 23: 435–45
- Jenkins D M., O'Neill M, Mattar M, France V M., Hsi B-L, Faulk W P. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol 1983; 90: 841–6